Is Biovie Stock a Good Investment?
Biovie Investment Advice | BIVI |
- Examine Biovie's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Biovie's leadership team and their track record. Good management can help Biovie navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Biovie's business and its evolving consumer preferences.
- Compare Biovie's performance and market position to its competitors. Analyze how Biovie is positioned in terms of product offerings, innovation, and market share.
- Check if Biovie pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Biovie's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Biovie Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Biovie Inc is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Biovie Stock
Researching Biovie's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 14.0% of the company shares are held by company insiders. The book value of Biovie was currently reported as 2.51. The company recorded a loss per share of 5.08. Biovie Inc last dividend was issued on the 22nd of November 2019. The entity had 1:10 split on the 6th of August 2024.
To determine if Biovie is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Biovie's research are outlined below:
| Biovie Inc is way too risky over 90 days horizon | |
| Biovie Inc appears to be risky and price may revert if volatility continues | |
| Biovie Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (32.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovie Inc currently holds about 18.64 M in cash with (27.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62. | |
| Biovie Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference |
Biovie Quarterly Good Will |
|
Biovie uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Biovie Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biovie's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 9th of February 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of August 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Biovie's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Biovie's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-09-27 | 2022-06-30 | -0.37 | -0.33 | 0.04 | 10 | ||
2023-05-12 | 2023-03-31 | -0.35 | -0.43 | -0.08 | 22 | ||
2024-02-13 | 2023-12-31 | -0.32 | -0.22 | 0.1 | 31 | ||
2022-11-04 | 2022-09-30 | -0.28 | -0.38 | -0.1 | 35 | ||
2021-01-29 | 2020-12-31 | -0.12 | -0.22 | -0.1 | 83 | ||
2024-05-14 | 2024-03-31 | -0.33 | -0.22 | 0.11 | 33 | ||
2022-05-11 | 2022-03-31 | -0.42 | -0.28 | 0.14 | 33 | ||
2023-08-16 | 2023-06-30 | -0.4 | -0.25 | 0.15 | 37 |
Know Biovie's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Biovie is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biovie Inc backward and forwards among themselves. Biovie's institutional investor refers to the entity that pools money to purchase Biovie's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wells Fargo & Co | 2024-09-30 | 550 | Cwm, Llc Duplicate | 2024-06-30 | 215 | Bank Of America Corp | 2024-09-30 | 112 | Steward Partners Investment Advisory, Llc | 2024-09-30 | 100.0 | Goss Wealth Management Llc | 2024-09-30 | 100.0 | Flaharty Asset Management, Llc | 2024-09-30 | 100.0 | Jpmorgan Chase & Co | 2024-09-30 | 77.0 | Financial Perspectives Inc | 2024-09-30 | 59.0 | Ubs Group Ag | 2024-09-30 | 45.0 | Vanguard Group Inc | 2024-09-30 | 56.8 K | Geode Capital Management, Llc | 2024-09-30 | 38.2 K |
Biovie's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.04 M.Market Cap |
|
Biovie's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.31) | (1.38) | |
| Return On Capital Employed | (2.03) | (2.13) | |
| Return On Assets | (1.27) | (1.34) | |
| Return On Equity | (2.07) | (2.18) |
Determining Biovie's profitability involves analyzing its financial statements and using various financial metrics to determine if Biovie is a good buy. For example, gross profit margin measures Biovie's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Biovie's profitability and make more informed investment decisions.
Evaluate Biovie's management efficiency
Biovie Inc has return on total asset (ROA) of (0.6669) % which means that it has lost $0.6669 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0826) %, meaning that it created substantial loss on money invested by shareholders. Biovie's management efficiency ratios could be used to measure how well Biovie manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.38. The current Return On Capital Employed is estimated to decrease to -2.13. As of now, Biovie's Non Current Assets Total are increasing as compared to previous years. The Biovie's current Other Assets is estimated to increase to 5,509, while Non Currrent Assets Other are projected to decrease to 0.00.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.43 | 3.72 | |
| Tangible Book Value Per Share | 3.26 | 3.43 | |
| Enterprise Value Over EBITDA | (0.03) | (0.03) | |
| Price Book Value Ratio | 1.22 | 1.15 | |
| Enterprise Value Multiple | (0.03) | (0.03) | |
| Price Fair Value | 1.22 | 1.15 | |
| Enterprise Value | 998.9 K | 887.9 K |
The leadership approach at Biovie's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.902 |
Basic technical analysis of Biovie Stock
As of the 11th of December 2024, Biovie shows the Risk Adjusted Performance of 0.0671, mean deviation of 7.66, and Downside Deviation of 12.46. Biovie Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biovie's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biovie insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biovie's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biovie insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biovie's Outstanding Corporate Bonds
Biovie issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biovie Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biovie bonds can be classified according to their maturity, which is the date when Biovie Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand Biovie's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Biovie's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0671 | |||
| Market Risk Adjusted Performance | (2.29) | |||
| Mean Deviation | 7.66 | |||
| Semi Deviation | 10.87 | |||
| Downside Deviation | 12.46 | |||
| Coefficient Of Variation | 1255.81 | |||
| Standard Deviation | 16.91 | |||
| Variance | 286.06 | |||
| Information Ratio | 0.0723 | |||
| Jensen Alpha | 1.4 | |||
| Total Risk Alpha | (1.34) | |||
| Sortino Ratio | 0.0981 | |||
| Treynor Ratio | (2.30) | |||
| Maximum Drawdown | 133.33 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 11.91 | |||
| Downside Variance | 155.33 | |||
| Semi Variance | 118.19 | |||
| Expected Short fall | (9.13) | |||
| Skewness | 3.51 | |||
| Kurtosis | 28.15 |
| Risk Adjusted Performance | 0.0671 | |||
| Market Risk Adjusted Performance | (2.29) | |||
| Mean Deviation | 7.66 | |||
| Semi Deviation | 10.87 | |||
| Downside Deviation | 12.46 | |||
| Coefficient Of Variation | 1255.81 | |||
| Standard Deviation | 16.91 | |||
| Variance | 286.06 | |||
| Information Ratio | 0.0723 | |||
| Jensen Alpha | 1.4 | |||
| Total Risk Alpha | (1.34) | |||
| Sortino Ratio | 0.0981 | |||
| Treynor Ratio | (2.30) | |||
| Maximum Drawdown | 133.33 | |||
| Value At Risk | (9.48) | |||
| Potential Upside | 11.91 | |||
| Downside Variance | 155.33 | |||
| Semi Variance | 118.19 | |||
| Expected Short fall | (9.13) | |||
| Skewness | 3.51 | |||
| Kurtosis | 28.15 |
Consider Biovie's intraday indicators
Biovie intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biovie stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 38517.63 | |||
| Daily Balance Of Power | (0.50) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.73 | |||
| Day Typical Price | 2.72 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.06) | |||
| Relative Strength Index | 48.37 |
Biovie Corporate Filings
| 2nd of December 2024 Other Reports | ViewVerify | |
| 27th of November 2024 Other Reports | ViewVerify | |
| 22nd of November 2024 Other Reports | ViewVerify | |
S1 | 21st of November 2024 Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
Biovie Stock media impact
Far too much social signal, news, headlines, and media speculation about Biovie that are available to investors today. That information is available publicly through Biovie media outlets and privately through word of mouth or via Biovie internal channels. However, regardless of the origin, that massive amount of Biovie data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biovie news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biovie relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biovie's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biovie alpha.
Biovie Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Biovie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biovie Corporate Management
| Joseph MD | Executive Officer | Profile | |
| Clarence Ahlem | Senior Operations | Profile | |
| Joanne CPA | Treasurer CFO | Profile | |
| Denise Smith | Senior Development | Profile | |
| Sarah Hoit | Chief Officer | Profile | |
| MBA MBA | CEO Pres | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Return On Assets (0.67) | Return On Equity (2.08) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Biovie's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.